| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/CCM.0B013E318232DB65 |
| P698 | PubMed publication ID | 21963582 |
| P50 | author | Penelope Pekow | Q114424461 |
| P2093 | author name string | Michael B Rothberg | |
| Peter K Lindenauer | |||
| Tara Lagu | |||
| Jay S Steingrub | |||
| Meng-Shiou Shieh | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | sepsis | Q183134 |
| hospitalization | Q3140971 | ||
| P304 | page(s) | 754-761 | |
| P577 | publication date | 2012-03-01 | |
| P1433 | published in | Critical Care Medicine | Q5186605 |
| P1476 | title | Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007. | |
| P478 | volume | 40 |
| Q27318669 | A Neutrophil Phenotype Model for Extracorporeal Treatment of Sepsis |
| Q37312615 | A collaborative improvement project by an NHS Emergency Department and Scottish Ambulance Paramedics to improve the identification and delivery of sepsis 6 |
| Q55322381 | A novel heart rate variability based risk prediction model for septic patients presenting to the emergency department. |
| Q33882126 | A point-of-care microfluidic biochip for quantification of CD64 expression from whole blood for sepsis stratification. |
| Q55014990 | A risk-model for hospital mortality among patients with severe sepsis or septic shock based on German national administrative claims data. |
| Q36367878 | A widened pulse pressure: a potential valuable prognostic indicator of mortality in patients with sepsis |
| Q36053579 | Activation of Hepatic STAT3 Maintains Pulmonary Defense during Endotoxemia |
| Q36641728 | Activity and Predicted Nephrotoxicity of Synthetic Antibiotics Based on Polymyxin B. |
| Q26782884 | Acute Cholecystitis |
| Q36119404 | Acute-Phase Deaths from Murine Polymicrobial Sepsis Are Characterized by Innate Immune Suppression Rather Than Exhaustion |
| Q47554129 | Adjuvant role of SeptiFast to improve the diagnosis of sepsis in a large cohort of hematological patients |
| Q30235830 | Antipyretic Therapy in Critically Ill Septic Patients: A Systematic Review and Meta-Analysis |
| Q35622257 | Are there new approaches for diagnosis, therapy guidance and outcome prediction of sepsis? |
| Q36324945 | Ascorbate-dependent vasopressor synthesis: a rationale for vitamin C administration in severe sepsis and septic shock? |
| Q64136972 | Assessing Variability in Hospital-Level Mortality Among U.S. Medicare Beneficiaries With Hospitalizations for Severe Sepsis and Septic Shock |
| Q88891881 | Association between the Availability of Hospital-based Palliative Care and Treatment Intensity for Critically Ill Patients |
| Q42330831 | Attempting to define and refine vasopressin use in septic shock: the VANISH trial |
| Q92106779 | Autophagy Enhancing Contributes to the Organ Protective Effect of Alpha-Lipoic Acid in Septic Rats |
| Q37428528 | Beyond Blood Culture and Gram Stain Analysis: A Review of Molecular Techniques for the Early Detection of Bacteremia in Surgical Patients |
| Q38942650 | Biglycan up-regulated vascular endothelial growth factor (VEGF) expression and promoted angiogenesis in colon cancer |
| Q26785255 | Biomarkers for Sepsis: What Is and What Might Be? |
| Q38984436 | Case Volume-Outcomes Associations Among Patients With Severe Sepsis Who Underwent Interhospital Transfer |
| Q89505794 | Cell-free hemoglobin increases inflammation, lung apoptosis, and microvascular permeability in murine polymicrobial sepsis |
| Q38980437 | Cellular and viral microRNAs in sepsis: mechanisms of action and clinical applications |
| Q58711808 | Change in alkaline phosphatase activity associated with intensive care unit and hospital length of stay in patients with septic acute kidney injury on continuous renal replacement therapy |
| Q40209281 | Characteristics, incidence and temporal trends of sepsis in elderly patients undergoing surgery |
| Q93006916 | Charge Reductions Associated With Shorter Time to Recovery in Septic Shock |
| Q37204930 | Childhood asthma hospitalizations in the United States, 2000-2009. |
| Q37264816 | Chromogranin A levels and mortality in patients with severe sepsis |
| Q36293944 | Chronic kidney disease is associated with a higher 90-day mortality than other chronic medical conditions in patients with sepsis. |
| Q36933511 | Clarithromycin Leads to Long-Term Survival and Cost Benefit in Ventilator-Associated Pneumonia and Sepsis |
| Q37624032 | Clinical Features, Short-Term Mortality, and Prognostic Risk Factors of Septic Patients Admitted to Internal Medicine Units: Results of an Italian Multicenter Prospective Study |
| Q37649004 | Clinical and Experimental Sepsis Impairs CD8 T-Cell-Mediated Immunity |
| Q51545819 | Cold-inducible RNA-binding protein activates splenic T cells during sepsis in a TLR4-dependent manner. |
| Q40503612 | Combining Biomarkers with EMR Data to Identify Patients in Different Phases of Sepsis. |
| Q47762179 | Comorbidities Might Condition the Recovery of Quality of Life in Survivors of Sepsis |
| Q91811931 | Comparing clinical judgment with the MySurgeryRisk algorithm for preoperative risk assessment: A pilot usability study |
| Q56889251 | Comparing the validity of different ICD coding abstraction strategies for sepsis case identification in German claims data |
| Q33754235 | Comparison of outcomes from sepsis between patients with and without pre-existing left ventricular dysfunction: a case-control analysis |
| Q53700898 | Comparison of septic shock due to MDR Acinetobacter baumannii or Klebsiella pneumoniae carbapenemase-producing K. pneumoniae in ICU patients. |
| Q30855320 | Comparison of trends in sepsis incidence and coding using administrative claims versus objective clinical data |
| Q33722631 | Concise Review: Mesenchymal Stromal Cell-Based Approaches for the Treatment of Acute Respiratory Distress and Sepsis Syndromes |
| Q38059857 | Confronting the threat of multidrug-resistant Gram-negative bacteria in critically ill patients |
| Q36073389 | Contemporary Trends of Reported Sepsis Among Maternal Decedents in Texas: A Population-Based Study |
| Q28391653 | Contemporary trends of the epidemiology, clinical characteristics, and resource utilization of necrotizing fasciitis in Texas: a population-based cohort study |
| Q47408851 | Critical illness among adults with cystic fibrosis in Texas, 2004-2013: Patterns of ICU utilization, characteristics, and outcomes. |
| Q26849252 | Current challenges in understanding immune cell functions during septic syndromes |
| Q35122727 | Current knowledge and future directions of TLR and NOD signaling in sepsis |
| Q92957195 | Current understanding of tumor lysis syndrome |
| Q26768292 | Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) |
| Q54257281 | Diagnostic Value of Procalcitonin in Predicting Bacteremia in Intensive Care Unit. |
| Q54211933 | Diagnostic value of decoy receptor 3 combined with procalcitonin and soluble urokinase-type plasminogen activator receptor for sepsis. |
| Q42370352 | Did the beneficial renal outcomes with vasopressin VANISH? |
| Q55500291 | Different concentrations of lipopolysaccharide regulate barrier function through the PI3K/Akt signalling pathway in human pulmonary microvascular endothelial cells. |
| Q35674736 | Early and late unplanned rehospitalizations for survivors of critical illness*. |
| Q35946841 | Early goal-directed resuscitation for patients with severe sepsis and septic shock: a meta-analysis and trial sequential analysis |
| Q35957492 | Effect of Cholecalciferol Supplementation on Vitamin D Status and Cathelicidin Levels in Sepsis: A Randomized, Placebo-Controlled Trial |
| Q36670553 | Effect of early goal-directed therapy on mortality in patients with severe sepsis or septic shock: a meta-analysis of randomised controlled trials |
| Q24200832 | Effectiveness and safety of procalcitonin evaluation for reducing mortality in adult patients with sepsis, severe sepsis and septic shock |
| Q30238953 | Effectiveness and safety of procalcitonin evaluation for reducing mortality in adults with sepsis, severe sepsis or septic shock |
| Q40812720 | Effects of Electro-Acupuncture at Zusanli, Guanyuan for Sepsis Patients and Its Mechanism through Immune Regulation |
| Q98771798 | Efficient Early Diagnosis of Sepsis Using Whole-Blood PCR-Reverse Blot Hybridization Assay Depending on Serum Procalcitonin Levels |
| Q50721291 | Endotoxaemia-augmented murine venous thrombosis is dependent on TLR-4 and ICAM-1, and potentiated by neutropenia. |
| Q92983381 | Epidemiological Characteristics of Postoperative Sepsis |
| Q49288765 | Epidemiological trends of sepsis in the twenty-first century (2000-2013): an analysis of incidence, mortality, and associated costs in Spain. |
| Q38541206 | Epidemiology and Microbiology of Sepsis Syndromes in a University-Affiliated Urban Teaching Hospital and Level-1 Trauma and Burn Center |
| Q37328684 | Epidemiology and Outcome of Severe Sepsis and Septic Shock in Surgical Intensive Care Units in Northern Taiwan |
| Q92354046 | Epidemiology and Trends of Sepsis in Young Adults Aged 20-44 Years: A Nationwide Population-Based Study |
| Q47134537 | Epidemiology and impact on all-cause mortality of sepsis in Norwegian hospitals: A national retrospective study. |
| Q36589163 | Epidemiology and outcomes of acute respiratory failure in the United States, 2001 to 2009: a national survey |
| Q92540430 | Epidemiology and outcomes of sepsis among hospitalizations with systemic lupus erythematosus admitted to the ICU: a population-based cohort study |
| Q21999482 | Epidemiology and recent trends of severe sepsis in Spain: a nationwide population-based analysis (2006-2011) |
| Q37559894 | Epidemiology of Pregnancy-Associated ICU Utilization in Texas: 2001 - 2010. |
| Q40284214 | Epidemiology of Sepsis and Its Recognition by Emergency Medical Services Personnel in the Netherlands. |
| Q55092121 | Epidemiology of sepsis in Brazil: Incidence, lethality, costs, and other indicators for Brazilian Unified Health System hospitalizations from 2006 to 2015. |
| Q37653366 | Epidemiology of sepsis in Catalonia: analysis of incidence and outcomes in a European setting |
| Q64108888 | Epidemiology of sepsis in Taiwan |
| Q93172729 | Epigenetic and metabolic programming of innate immunity in sepsis |
| Q27026804 | Evaluation of vitamin C for adjuvant sepsis therapy |
| Q38926636 | Evolution of Sepsis Management: From Early Goal-Directed Therapy to Personalized Care |
| Q35387173 | Evolving trends in the epidemiology, resource utilization, and outcomes of pregnancy-associated severe sepsis: a population-based cohort study |
| Q93124035 | Exosome-delivered syndecan-1 rescues acute lung injury via a FAK/p190RhoGAP/RhoA/ROCK/NF-κB signaling axis and glycocalyx enhancement |
| Q34290672 | Formal modelling of toll like receptor 4 and JAK/STAT signalling pathways: insight into the roles of SOCS-1, interferon-β and proinflammatory cytokines in sepsis |
| Q35065285 | Functional outcomes of general medical patients with severe sepsis. |
| Q35041304 | Genome-wide association study of survival from sepsis due to pneumonia: an observational cohort study |
| Q52325721 | Getting the invite list right: a discussion of sepsis severity scoring systems in severe complicated intra-abdominal sepsis and randomized trial inclusion criteria. |
| Q26777964 | HDL in sepsis - risk factor and therapeutic approach |
| Q36758021 | HMGB1 mediates anemia of inflammation in murine sepsis survivors. |
| Q37337981 | Heart failure–associated hospitalizations in the United States |
| Q64257334 | Heart rate variability based machine learning models for risk prediction of suspected sepsis patients in the emergency department |
| Q39363554 | High-sensitivity cardiac troponin T is an independent predictor of inhospital mortality in emergency department patients with suspected infection: a prospective observational derivation study |
| Q36747916 | Hospital Incidence and Mortality Rates of Sepsis |
| Q37685516 | Hospital costs and inpatient mortality among children undergoing surgery for congenital heart disease |
| Q34561775 | Hospital readmission and healthcare utilization following sepsis in community settings. |
| Q35177518 | Hospital-based acute care use in survivors of septic shock |
| Q26864635 | Host innate immune responses to sepsis |
| Q92469045 | How Clinical Flow Cytometry Rebooted Sepsis Immunology |
| Q35247557 | Human metabolic response to systemic inflammation: assessment of the concordance between experimental endotoxemia and clinical cases of sepsis/SIRS. |
| Q24193361 | Hydroxymethylglutaryl-CoA reductase inhibitors (statins) for the treatment of sepsis |
| Q38161073 | Hypercapnia: is it protective in lung injury? |
| Q36422751 | Hyperlactatemia affects the association of hyperglycemia with mortality in nondiabetic adults with sepsis |
| Q42512567 | IL-7 Restores T Lymphocyte Immunometabolic Failure in Septic Shock Patients through mTOR Activation. |
| Q36992432 | Identification of CD163 as an antiinflammatory receptor for HMGB1-haptoglobin complexes |
| Q30249170 | Identifying Patients With Sepsis on the Hospital Wards |
| Q36598596 | Identifying patients with severe sepsis using administrative claims: patient-level validation of the angus implementation of the international consensus conference definition of severe sepsis |
| Q36635695 | Impact of Policies on the Rise in Sepsis Incidence, 2000-2010 |
| Q90331229 | Impact of polymyxin B hemoperfusion in the treatment of patients with sepsis and septic shock: a meta-analysis of randomized controlled trials |
| Q90392595 | Impact of the pre-illness lipid profile on sepsis mortality |
| Q45836220 | Implementation of sepsis bundles in public hospitals in Brazil: a prospective study with heterogeneous results. |
| Q64267206 | Improving clinical outcomes in sepsis and multiple organ dysfunction through precision medicine |
| Q33425845 | Improving documentation and coding for acute organ dysfunction biases estimates of changing sepsis severity and burden: a retrospective study |
| Q38697751 | In Search of a Cure for Sepsis: Taming the Monster in Critical Care Medicine. |
| Q40287350 | In Vitro Study of Antimicrobial Percutaneous Nephrostomy Catheters for Prevention of Renal Infections |
| Q40048733 | Incidence and Trends of Sepsis in US Hospitals Using Clinical vs Claims Data, 2009-2014. |
| Q92590163 | Incidence, trends, and outcomes of infection sites among hospitalizations of sepsis: A nationwide study |
| Q38007121 | Incorporating initial treatments improves performance of a mortality prediction model for patients with sepsis |
| Q42857128 | Increased FGF21 plasma levels in humans with sepsis and SIRS. |
| Q35115833 | Increased coagulation and suppressed generation of activated protein C in aged mice during intra-abdominal sepsis |
| Q38920501 | Infection-related health care utilization among people with and without multiple sclerosis. |
| Q47646437 | Influence of Prehospital Function and Strength on Outcomes of Critically Ill Older Adults |
| Q39012734 | Insight into the beneficial immunomodulatory mechanism of the sevoflurane metabolite hexafluoro-2-propanol in a rat model of endotoxaemia |
| Q37376812 | Intensive Care Unit (ICU) - Managed Elderly Hospitalizations with Dementia in Texas, 2001-2010: A Population-Level Analysis. |
| Q36689362 | Intestine-Derived Matrix Metalloproteinase-8 Is a Critical Mediator of Polymicrobial Peritonitis |
| Q40122581 | Investigating the Impact of Different Suspicion of Infection Criteria on the Accuracy of Quick Sepsis-Related Organ Failure Assessment, Systemic Inflammatory Response Syndrome, and Early Warning Scores |
| Q50594267 | LRP1-Dependent BMPER Signaling Regulates Lipopolysaccharide-Induced Vascular Inflammation. |
| Q40438507 | Late Therapeutic Intervention with Antibiotics and Fluid Resuscitation Allows for a Prolonged Disease Course with High Survival in a Severe Murine Model of Sepsis |
| Q89679313 | Long-term mortality and outcome in hospital survivors of septic shock, sepsis, and severe infections: The importance of aftercare |
| Q26823225 | Lysosome and Cytoskeleton Pathways Are Robustly Enriched in the Blood of Septic Patients: A Meta-Analysis of Transcriptomic Data |
| Q60759037 | Machine learning as a supportive tool to recognize cardiac arrest in emergency calls |
| Q39139022 | Mass spectrometry for the discovery of biomarkers of sepsis |
| Q37353938 | Matrix Metalloproteinase-8 Augments Bacterial Clearance in a Juvenile Sepsis Model. |
| Q35205670 | Mesenchymal stem cells as a therapeutic tool to treat sepsis |
| Q39099480 | Microbial recognition and danger signals in sepsis and trauma |
| Q36447748 | Milk fat globule-epidermal growth factor-factor VIII downregulates interleukin-17 expression in sepsis by modulating STAT3 activation |
| Q35163917 | Mobilization in severe sepsis: an integrative review. |
| Q98178817 | Modified early warning score-based clinical decision support: cost impact and clinical outcomes in sepsis |
| Q38286512 | Molecular diagnosis of sepsis: New aspects and recent developments |
| Q37020986 | Mortality Associated with Severe Sepsis Among Age-Similar Women with and without Pregnancy-Associated Hospitalization in Texas: A Population-Based Study |
| Q34450365 | Mortality predictors in renal transplant recipients with severe sepsis and septic shock |
| Q36052263 | Mortality trends in U.S. adults with septic shock, 2005-2011: a serial cross-sectional analysis of nationally-representative data. |
| Q38690754 | Murine Models of Sepsis and Trauma: Can We Bridge the Gap? |
| Q33786718 | Myeloid-derived suppressor cells in sepsis |
| Q35885259 | National Lupus Hospitalization Trends Reveal Rising Rates of Herpes Zoster and Declines in Pneumocystis Pneumonia |
| Q36429714 | Necrotizing Fasciitis Among Patients With Liver Cirrhosis in Texas, 2001 - 2010: A Population-Based Cohort Study |
| Q28384387 | Necrotizing Fasciitis Associated with Pregnancy: a Population-Based Cohort Study |
| Q64106613 | Neutrophils disturb pulmonary microcirculation in sepsis-induced acute lung injury |
| Q40836443 | Nonhematopoietic Peroxisome Proliferator-Activated Receptor-α Protects Against Cardiac Injury and Enhances Survival in Experimental Polymicrobial Sepsis |
| Q36002077 | Obesity and Mortality, Length of Stay and Hospital Cost among Patients with Sepsis: A Nationwide Inpatient Retrospective Cohort Study |
| Q31015229 | Objective Sepsis Surveillance Using Electronic Clinical Data |
| Q101409988 | Oroxylin A alleviates immunoparalysis of CLP mice by degrading CHOP through interacting with FBXO15 |
| Q36753909 | Overview of progresses in critical care medicine 2012. |
| Q37091086 | PIRO concept: staging of sepsis |
| Q38141738 | Pathophysiologic mechanisms in septic shock |
| Q35761448 | Pathophysiology of sepsis-related cardiac dysfunction: driven by inflammation, energy mismanagement, or both? |
| Q36223740 | Patterns of the Demographics, Clinical Characteristics, and Resource Utilization Among Maternal Decedents in Texas, 2001 - 2010: A Population-Based Cohort Study |
| Q90070610 | Peroxynitrite decomposition catalyst reduces vasopressin requirement in ovine MRSA sepsis |
| Q35184876 | Persistent lymphopenia after diagnosis of sepsis predicts mortality. |
| Q38828672 | Physician Variation in Time to Antimicrobial Treatment for Septic Patients Presenting to the Emergency Department |
| Q90254502 | Point-of-care sensors for the management of sepsis |
| Q38889679 | Potentially Avoidable Pediatric Interfacility Transfer Is a Costly Burden for Rural Families: A Cohort Study. |
| Q90462435 | Potentially Preventable Intensive Care Unit Admissions in the United States, 2006-2015 |
| Q37015501 | Predicting and Eventually Preventing the Future: Sepsis Risk in Community-Dwelling Adults |
| Q41646872 | Prediction of outcome from community-acquired severe sepsis and septic shock in tertiary-care university hospital in a developing country |
| Q90647556 | Predictors of Urinary Infections and Urosepsis After Ureteroscopy for Stone Disease: a Systematic Review from EAU Section of Urolithiasis (EULIS) |
| Q26864623 | Pregnancy-Associated Severe Sepsis: Contemporary State and Future Challenges |
| Q64122576 | Prehospital Care and Emergency Department Door-to-Antibiotic Time in Sepsis |
| Q39727191 | Preoperative assessment of the risk for multiple complications after surgery |
| Q55709899 | Prevention and management of urosepsis triggered by ureteroscopy. |
| Q36006620 | Prognostic Implications of Serum Lipid Metabolism over Time during Sepsis |
| Q37006956 | Prognostic factors in patients with septic shock in digestive surgery who have undergone direct hemoperfusion with polymyxin B-immobilized fibers: a retrospective observational study |
| Q35132036 | Propofol increases morbidity and mortality in a rat model of sepsis |
| Q40603944 | Protective effect of recombinant Trichinella 53-kDa protein in sepsis and the effect on macrophages |
| Q37151525 | Proton pump inhibitors protect mice from acute systemic inflammation and induce long-term cross-tolerance. |
| Q36395980 | Quantifying the improvement in sepsis diagnosis, documentation, and coding: the marginal causal effect of year of hospitalization on sepsis diagnosis |
| Q40533921 | Quick Sepsis-related Organ Failure Assessment, Systemic Inflammatory Response Syndrome, and Early Warning Scores for Detecting Clinical Deterioration in Infected Patients outside the Intensive Care Unit |
| Q91693290 | Re-Evaluating Biologic Pharmacotherapies that Target the Host Response during Sepsis |
| Q39053045 | Reasons for death in patients with sepsis and septic shock. |
| Q58605309 | Reduction in the IL-6 level at 24 h after admission to the intensive care unit is a survival predictor for Vietnamese patients with sepsis and septic shock: a prospective study |
| Q37660699 | Regulatory effect and mechanisms of carbon monoxide-releasing molecule II on hepatic energy metabolism in septic mice |
| Q36478608 | Regulatory mandates for sepsis care--reasons for caution |
| Q37300484 | Rehospitalizations Following Sepsis: Common and Costly |
| Q41203002 | Relevance of Candida and other mycoses for morbidity and mortality in severe sepsis and septic shock due to peritonitis |
| Q64243147 | Risk Factors for Same Pathogen Sepsis Readmission Following Hospitalization for Septic Shock |
| Q36945095 | Risk Stratification and Prognosis in Sepsis: What Have We Learned from Microarrays? |
| Q33750986 | Risk stratification and prognostic performance of the predisposition, infection, response, and organ dysfunction (PIRO) scoring system in septic patients in the emergency department: a cohort study |
| Q37620811 | Role of the IL-33-ST2 axis in sepsis |
| Q90449792 | Sepsis Patients in Critical Care Units with Obesity: Is Obesity Protective? |
| Q38618741 | Sepsis at a Safety Net Hospital: Risk Factors Associated With 30-Day Readmission |
| Q36902936 | Sepsis biomarkers in unselected patients on admission to intensive or high-dependency care |
| Q30881137 | Sepsis in Canadian children: a national analysis using administrative data. |
| Q59796343 | Sepsis in Intensive Care Unit Patients: Worldwide data from the ICON audit |
| Q39315970 | Sepsis in Internal Medicine wards: current knowledge, uncertainties and new approaches for management optimization. |
| Q37665355 | Sepsis in old age: review of human and animal studies |
| Q35603020 | Sepsis outcomes in patients receiving statins prior to hospitalization for sepsis: comparison of in-hospital mortality rates between patients who received atorvastatin and those who received simvastatin. |
| Q31127051 | Sepsis surveillance from administrative data in the absence of a perfect verification. |
| Q90150898 | Sepsis trends: increasing incidence and decreasing mortality, or changing denominator? |
| Q34558763 | Sepsis-related deaths in Brazil: an analysis of the national mortality registry from 2002 to 2010 |
| Q64137586 | Sepsis-related mortality in China: a descriptive analysis |
| Q38595341 | Sepsis: contemporary issues and implications for nursing |
| Q37655890 | Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding |
| Q38135863 | Septic shock: desperately seeking treatment |
| Q92064103 | Serial Heart Rate Variability Measures for Risk Prediction of Septic Patients in the Emergency Department |
| Q45897995 | Severe infections : causes and management of sepsis |
| Q37261296 | Severe sepsis cohorts derived from claims-based strategies appear to be biased toward a more severely ill patient population |
| Q36755085 | Severe sepsis in pre-hospital emergency care: analysis of incidence, care, and outcome |
| Q36144916 | Shorter Duration of Post-Operative Antibiotics for Cecal Ligation and Puncture Does Not Increase Inflammation or Mortality |
| Q47098617 | Sialic Acids in the Immune Response during Sepsis |
| Q90430881 | Simvastatin preparations promote PDGF-BB secretion to repair LPS-induced endothelial injury through the PDGFRβ/PI3K/Akt/IQGAP1 signalling pathway |
| Q90511412 | Start a fire, kill the bug: The role of platelets in inflammation and infection |
| Q34657881 | Systemic inflammatory response syndrome (SIRS): where did it come from and is it still relevant today? |
| Q35612189 | TAT-HSP70 Attenuates Experimental Lung Injury |
| Q36658546 | Temporal Trends of the Clinical, Resource Use and Outcome Attributes of ICU-Managed Candidemia Hospitalizations: A Population-Level Analysis |
| Q37700018 | Temporal trends in emergency department visits for bronchiolitis in the United States, 2006 to 2010. |
| Q90647140 | The "Centrality of Sepsis": A Review on Incidence, Mortality, and Cost of Care |
| Q35660734 | The CD14 rs2569190 TT Genotype Is Associated with an Improved 30-Day Survival in Patients with Sepsis: A Prospective Observational Cohort Study |
| Q38455028 | The Economic and Humanistic Burden of Severe Sepsis |
| Q46278083 | The GENESIS project (GENeralized Early Sepsis Intervention Strategies): a multicenter quality improvement collaborative |
| Q49211200 | The German Quality Network Sepsis: study protocol for the evaluation of a quality collaborative on decreasing sepsis-related mortality in a quasi-experimental difference-in-differences design. |
| Q41661030 | The Lactate/Albumin Ratio: A Valuable Tool for Risk Stratification in Septic Patients Admitted to ICU. |
| Q35017059 | The Nociceptin/Orphanin FQ system is modulated in patients admitted to ICU with sepsis and after cardiopulmonary bypass. |
| Q40397547 | The Risk of Sepsis with Inhaled and Oral Corticosteroids in Patients with COPD. |
| Q89448062 | The ability of an improved qSOFA score to predict acute sepsis severity and prognosis among adult patients |
| Q35633515 | The association between time to antibiotics and relevant clinical outcomes in emergency department patients with various stages of sepsis: a prospective multi-center study |
| Q38649207 | The delta neutrophil index is a prognostic factor for postoperative mortality in patients with sepsis caused by peritonitis |
| Q43827300 | The effect of obesity on clinical outcomes in presumed sepsis: a retrospective cohort study |
| Q40229508 | The haptoglobin beta subunit sequesters HMGB1 toxicity in sterile and infectious inflammation |
| Q41108166 | The prognostic performance of the complement system in septic patients in emergency department: a cohort study |
| Q40214469 | The relationship between hospital volume and mortality in severe sepsis |
| Q37626268 | The temporal kinetics of circulating angiopoietin levels in children with sepsis |
| Q38790740 | Therapeutic drug monitoring of anti-infective agents in critically ill patients |
| Q58768908 | Treatment of patients with sepsis in a closed intensive care unit is associated with improved survival: a nationwide observational study in Japan |
| Q90160713 | Trends in Post-Acute Care Use after Admissions for Sepsis |
| Q36952246 | Trends in bronchiolitis hospitalizations in the United States, 2000-2009. |
| Q37058914 | Trichostatin A Protects Liver against Septic Injury through Inhibiting Toll-Like Receptor Signaling |
| Q35038284 | Two decades of mortality trends among patients with severe sepsis: a comparative meta-analysis*. |
| Q26801608 | Update of Sepsis: Recent Evidences about Early Goal Directed Therapy |
| Q40745354 | Urosepsis. Update on diagnosis and treatment |
| Q35224935 | Use of Systematic Methods to Improve Disease Identification in Administrative Data: The Case of Severe Sepsis |
| Q51748707 | Using lean methodology to optimize time to antibiotic administration in patients with sepsis. |
| Q37192250 | Utilization patterns and outcomes associated with central venous catheter in septic shock: a population-based study |
| Q36496205 | Variation in the Contents of Sepsis Bundles and Quality Measures. A Systematic Review |
| Q36976548 | Voluntary wheel running attenuates lipopolysaccharide-induced liver inflammation in mice |
| Q35639496 | Xuebijing Injection Promotes M2 Polarization of Macrophages and Improves Survival Rate in Septic Mice |
| Q52838188 | [Sepsis and septic shock : Overview after sepsis-3 and the requirements of the clinician regarding the autopsy of critically ill patients]. |
| Q41084535 | p32 is Required for Appropriate Interleukin-6 Production Upon LPS Stimulation and Protects Mice from Endotoxin Shock. |
| Q40071878 | qSOFA Has Poor Sensitivity for Prehospital Identification of Severe Sepsis and Septic Shock |
Search more.